tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Vitasora Health Lifts Revenue and Billing Productivity as CMS Changes and New Funding Support U.S. Growth

Story Highlights
  • Vitasora Health delivered higher revenue and billing productivity, growing patient programs despite fewer billing days.
  • CMS reimbursement changes and fresh capital are expected to support revenue uplift and fund Vitasora’s continued U.S. expansion.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Vitasora Health Lifts Revenue and Billing Productivity as CMS Changes and New Funding Support U.S. Growth

Claim 50% Off TipRanks Premium

Vitasora Health ( (AU:VHL) ) just unveiled an announcement.

Vitasora Health reported strong operational and revenue momentum for the quarter ended 31 December 2025, with average daily clinical billing up 22% quarter-on-quarter and on track to exceed September levels by more than 50% in January 2026, supported by workflow optimisation, improved platform capability and growing patient volumes. Operating revenue rose 17% sequentially and 136% year-on-year to A$1.25 million despite fewer effective billing days due to seasonal holidays, while active patient programs increased to 22,880, driven by new enrolments from key U.S. clients. The company highlighted that recent CMS CPT changes effective January 2026 are expected to boost reimbursement rates and expand billable services, potentially lifting 2026 revenue by 10–20% without adding clinical workload. Vitasora also reduced net operating cash outflows by 28% to A$3.5 million, aided by cost discipline and an R&D tax refund, and strengthened its balance sheet through the completion of an A$11 million funding package, leaving A$3.1 million in cash to support continued U.S. expansion.

The most recent analyst rating on (AU:VHL) stock is a Sell with a A$0.03 price target. To see the full list of analyst forecasts on Vitasora Health stock, see the AU:VHL Stock Forecast page.

More about Vitasora Health

Vitasora Health (ASX: VHL, OTCQB: VHLUF) operates in the digital healthcare and remote patient monitoring sector, providing technology-enabled clinical programs such as remote patient monitoring and chronic care management for U.S. primary care and health center partners, including Iris Medical Group and Tampa Family Health Center. The company focuses on scaling patient programs and improving billing productivity in the U.S. healthcare reimbursement environment, particularly under CMS codes for chronic and remote care services.

Average Trading Volume: 1,254,380

Technical Sentiment Signal: Sell

Current Market Cap: A$42.74M

Find detailed analytics on VHL stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1